CALGARY, July 29, 2019 /CNW/ - PRESS RELEASE - Candre Cannabis Inc. has been granted a standard cultivation, standard processing and sale for medical purposes license by Health Canada pursuant to the Cannabis Act and Cannabis Regulations.
In accordance with the Cannabis Act and Regulations declaration process, Candre has sourced and currently possesses a very diverse portfolio of cultivars consisting of over 140 unique cannabis strains, many of which are new to Canada's legal cannabis market.
"Candre is very excited to immediately begin cultivating while we develop and work towards bringing new and exciting strains to the market" says Jesse Beaudry, Candre's president and CEO. "The team has worked very hard to accomplish this goal and continues to deliver tremendous results."
